Related references
Note: Only part of the references are listed.Parkin Pathway Activation Mitigates Glioma Cell Proliferation and Predicts Patient Survival
Calvin W. S. Yeo et al.
CANCER RESEARCH (2012)
Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors
Karolina Edlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect
Cen Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
MUT-TP53 2.0: A Novel Versatile Matrix for Statistical Analysis of TP53 Mutations in Human Cancer
Thierry Soussi et al.
HUMAN MUTATION (2010)
Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies
Selvaraju Veeriah et al.
NATURE GENETICS (2010)
PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice
George Poulogiannis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
Michael Weller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease
Cristine Alves da Costa et al.
NATURE CELL BIOLOGY (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
Parkin as a tumor suppressor gene for hepatocellular carcinoma
M. Fujiwara et al.
ONCOGENE (2008)
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas
Ahmed Idbaih et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
The p53 knowledgebase: an integrated information resource for p53 research
Y. P. Lim et al.
ONCOGENE (2007)
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer
A. Letessier et al.
ONCOGENE (2007)
BCL2 family in DNA damage and cell cycle control
S. Zinkel et al.
CELL DEATH AND DIFFERENTIATION (2006)
The p53-Bcl-2 connection
M. T. Hemann et al.
CELL DEATH AND DIFFERENTIATION (2006)
Presenilin-dependent γ-secretase-mediated control of p53-associated cell death in Alzheimer's disease
CA da Costa et al.
JOURNAL OF NEUROSCIENCE (2006)
Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia
X Agirre et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Two types of chromosome 1p losses with opposite significance in gliomas
A Idbaih et al.
ANNALS OF NEUROLOGY (2005)
Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP
R Pardossi-Piquard et al.
NEURON (2005)
Pathogenic mutations inactivate parkin by distinct mechanisms
IH Henn et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer
MC Picchio et al.
CLINICAL CANCER RESEARCH (2004)
Parkin gene alterations in hepatocellular carcinoma
F Wang et al.
GENES CHROMOSOMES & CANCER (2004)
Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27 (Publication with Expression of Concern. See vol. 114, 2017)
R Cesari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Identification of a novel gene linked to parkin via a bi-directional promoter
AB West et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Effects of a novel synthetic retinoid on malignant glioma in vitro:: inhibition of cell proliferation, induction of apoptosis and differentiation
SL Costa et al.
EUROPEAN JOURNAL OF CANCER (2001)
Direct transactivation of c-Ha-Ras gene by p53:: evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis
V Deguin-Chambon et al.
ONCOGENE (2000)
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
H Shimura et al.
NATURE GENETICS (2000)